INVO Fertility Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	6.62	6.53	3.02
Revenue Growth (YoY)	119.16%	116.25%	-
Cost of Revenue	4.08	3.66	1.93
Gross Profit	2.54	2.87	1.09
Selling, General & Admin	8.74	9.08	7.49
Research & Development	0.48	0.49	0.17
Operating Expenses	10.09	10.49	7.85
Operating Income	-7.56	-7.61	-6.77
Interest Expense	-1.03	-1.06	-0.93
Currency Exchange Gain (Loss)	-	-	-0
EBT Excluding Unusual Items	-8.61	-8.67	-7.69
Gain (Loss) on Sale of Investments	0.01	0.01	-0.15
Gain (Loss) on Sale of Assets	-	-0.51	-
Other Unusual Items	0.02	0.05	-0.16
Pretax Income	-9.98	-9.12	-8.01
Income Tax Expense	-0.02	-0.02	0.03
Net Income	-27.94	-9.1	-8.03
Preferred Dividends & Other Adjustments	0.25	0.25	-
Net Income to Common	-28.19	-9.35	-8.03
Shares Outstanding (Basic)	0	0	0
Shares Outstanding (Diluted)	0	0	0
Shares Change (YoY)	428.38%	159.54%	-
EPS (Basic)	-134.22	-90.58	-202.10
EPS (Diluted)	-134.22	-90.58	-202.11
Free Cash Flow	-6.62	-3.16	-5.2
Free Cash Flow Per Share	-31.53	-30.61	-130.80
Gross Margin	38.30%	44.00%	35.96%
Operating Margin	-114.15%	-116.56%	-224.03%
Profit Margin	-425.88%	-143.09%	-266.00%
Free Cash Flow Margin	-100.06%	-48.35%	-172.14%
EBITDA	-6.69	-6.69	-6.57
EBITDA Margin	-101.06%	-102.48%	-217.38%
D&A For EBITDA	0.87	0.92	0.2
EBIT	-7.56	-7.61	-6.77
EBIT Margin	-114.15%	-116.56%	-224.03%
Revenue as Reported	6.62	6.53	3.02

Updated May 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q